Skip to main content
. 2023 Jan 19;22(3):291–294. doi: 10.1007/s10689-023-00327-2

Table 2.

Family history of the identified heterozygous CHEK2 c.1312 G > T, p.(Asp438Tyr) carriers

Index ID -Cancers/tumors
(age at diagnosis)
Breast/ovarian cancer(s) in 1st and/or 2nd degree relatives (age at diagnosis) Breast/ovarian cancer(s) in 3rd degree relatives (age at diagnosis) Other cancers in 1st and/or 2nd relatives (age at diagnosis)
Her1 -Bil Br (45, 48) Br (29) [-], Br (47) [+], Br (u) - Leukemia (65), Lung (u)
Her2 -Br (47) Br and Basalioma (64) [+], Br (u) Br (62) [-], Br (u) Pancreatic (50) [+]
Uns1 -Br (71) Br (72) - -
Uns2 -Br (66) Bil Br (u) - -
Uns3 -Br (62) Br (u) - Prostate and Bone (75)
Uns4 -Br (74) - - Stomach (48), Uterine (49), Brain (7)
Uns5 -Br (75) - - Leukemia (u)
Uns6 -Br (50) - - -
Uns7 -Br (53) - - -
Uns8 -Br (57) - - -
Uns9 -Br (53) - - -
Uns10 -Bil Br (44, 47) - - -
Uns11 -Br (54) - - -
Uns12 -Br (58) - - -

- : none reported, Br breast, Bil Br bilateral breast, u unknown disease onset age, Her hereditary cohort, Uns unselected cohort

All tested cases marked as [+], if positive and [-], if negative for CHEK2 c.1312 G > T, p.(Asp438Tyr)